Rosiglitazone → Rosiglitazone Maleate

HRID 2244601

반응식

HRID 2244601 반응식
[CH3:1][N:2]([CH2:9][CH2:10][O:11][C:12]1[CH:25]=[CH:24][C:15]([CH2:16][CH:17]2[S:21][C:20](=[O:22])[NH:19][C:18]2=[O:23])=[CH:14][CH:13]=1)[C:3]1[CH:8]=[CH:7][CH:6]=[CH:5][N:4]=1.[C:26]([OH:33])(=[O:32])/[CH:27]=[CH:28]\[C:29]([OH:31])=[O:30]>C(O)C>[CH3:1][N:2]([C:3]1[CH:8]=[CH:7][CH:6]=[CH:5][N:4]=1)[CH2:9][CH2:10][O:11][C:12]1[CH:25]=[CH:24][C:15]([CH2:16][CH:17]2[S:21][C:20](=[O:22])[NH:19][C:18]2=[O:23])=[CH:14][CH:13]=1.[CH:27](/[C:26]([OH:33])=[O:32])=[CH:28]/[C:29]([OH:31])=[O:30]

참가 물질

4

실험 절차

Rosiglitazone maleate was prepared according to the disclosure of WO 94/05659, in which 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione (470 gms) and maleic acid (137 gms) were dissolved in ethanol (4 ltrs) at boiling. The hot solution was filtered via diatomaceous earth and was then allowed to cool slowly with gentle agitation. After leaving in a refrigerator at 0-5° C. for several hours, the maleate salt was filtered off, washed with ethanol and dried in vacuum at 50° C. to give 446 gms of rosiglitazone maleate as provided by WO 94/05659. The product was characterized as Form-B by XRD & IR, as can be seen by reference to FIGS. 3 and 4 respectively.

후처리

  1. customRosiglitazone maleate was prepared
  2. filtrationThe hot solution was filtered via diatomaceous earth
  3. temperatureto cool slowly with gentle agitation
  4. customAfter leaving in a refrigerator at 0-5° C. for several hours
  5. filtrationthe maleate salt was filtered off
  6. washwashed with ethanol
  7. customdried in vacuum at 50° C.

출처 및 근거

ORD 기록
ord-368b645d364b48558588905343521725
출처 데이터셋
uspto-grants-2010_03
특허 번호
US07678916B2

연결된 노트

불러오는 중…